Veterinary Medicine Information website

PURMAZOLE 5 MG/ML ORAL SOLUTION FOR CATS

Authorised
  • Thiamazole
Download as PDF

Product identification

Medicine name:
PURMAZOLE 5 MG/ML ORAL SOLUTION FOR CATS
Active substance:
  • Thiamazole
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Thiamazole
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Cardboard box with 1 bottle of 30 mL and 1 oral syringe of 1 mL.
  • Cardboard box with 1 bottle of 100 mL and 1 oral syringe of 1 mL.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application - change in active substance(s) (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6497894 3/2026
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0517/001
Concerned member states:
  • Germany
  • Italy
  • Romania
  • Spain

Documents

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 2/04/2026
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 2/04/2026
Download

Combined File of all Documents

English (PDF)
Published on: 2/04/2026
Download

eu-puar-frv0517001-mr-rpe1012-en.pdf

English (PDF)
Published on: 5/05/2026
Download